{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:36:48Z","timestamp":1773275808726,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.expneurol.2005.10.022","type":"journal-article","created":{"date-parts":[[2005,12,10]],"date-time":"2005-12-10T09:06:00Z","timestamp":1134205560000},"page":"363-372","source":"Crossref","is-referenced-by-count":41,"title":["Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys"],"prefix":"10.1016","volume":"197","author":[{"given":"Krystof S.","family":"Bankiewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Daadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Pivirotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Bringas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Sanftner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Forsayeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie L.","family":"Eberling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2005.10.022_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(91)90960-4","article-title":"Dopamine receptor changes in untreated and (+)-PHNO-treated MPTP parkinsonian primates","volume":"547","author":"Alexander","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2005.10.022_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1006\/exnr.2000.7408","article-title":"Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach","volume":"164","author":"Bankiewicz","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2005.10.022_bib3","first-page":"113","article-title":"Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys","volume":"60","author":"Bedard","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.expneurol.2005.10.022_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mds.870050103","article-title":"Induction of chorea and dystonia in parkinsonian primates","volume":"5","author":"Boyce","year":"1990","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2005.10.022_bib5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0306-4522(94)00431-4","article-title":"Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease","volume":"64","author":"Burns","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2005.10.022_bib6","first-page":"181","article-title":"Striatal dopamine receptive system changes and motor response complications in l-dopa-treated patients with advance disease","volume":"60","author":"Chase","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.expneurol.2005.10.022_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/1531-8257(200005)15:3<459::AID-MDS1006>3.0.CO;2-3","article-title":"Relationship among nigrostriatal denervation, parkinsonism and dyskinesias in the MPTP primate model","volume":"15","author":"Di Monte","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2005.10.022_bib8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ymthe.2003.09.013","article-title":"In vivo PET imaging of gene expression in parkinsonian monkeys","volume":"8","author":"Eberling","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2005.10.022_bib9","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson\u2019s disease","volume":"344","author":"Freed","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2005.10.022_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0006-8993(93)90694-I","article-title":"Differential effect of chronic dopaminergic treatment on dopamine D-1 and D-2 receptors in the monkey brain in MPTP-induced parkinsonism","volume":"602","author":"Graham","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.10.022_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.410270507","article-title":"l-dopa pharmacokinetics in plasma and cisternal and lumbar cerebrospinal fluid of monkeys","volume":"27","author":"Hammerstad","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.10.022_bib12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0006-8993(96)01366-2","article-title":"6-[18F]fluoro-l-m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primates","volume":"750","author":"Jordan","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.10.022_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0079-6123(00)27016-7","article-title":"Neuropathology of fetal nigra transplants for Parkinson\u2019s disease","volume":"127","author":"Kordower","year":"2000","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2005.10.022_bib14","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ana.10359","article-title":"Dyskinesia after fetal cell transplantation for parkinsonism: a PET study","volume":"52","author":"Ma","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.10.022_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.870090103","article-title":"Levodopa-induced dyskinesias in Parkinson\u2019s disease phenomenology and pathophysiology","volume":"9","author":"Marconi","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2005.10.022_bib16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/jnnp.34.6.668","article-title":"Analysis of l-dopa induced dyskinesias in 51 patients with Parkinsonism","volume":"34","author":"Mones","year":"1971","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2005.10.022_bib17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ana.410220406","article-title":"Motor fluctuations in Parkinson\u2019s disease: pathogenic and therapeutic studies","volume":"22","author":"Mouradian","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.10.022_bib18","series-title":"Drug-Induced Movement Disorders","first-page":"281","article-title":"Dyskinesia induced by levodopa and dopamine agonists in patients with Parkinson\u2019s disease","author":"Nutt","year":"1992"},{"key":"10.1016\/j.expneurol.2005.10.022_bib19","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1471-1931(00)00031-8","article-title":"Levodopa motor complications in Parkinson\u2019s disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci,"},{"key":"10.1016\/j.expneurol.2005.10.022_bib20","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S1471-1931(00)00028-8","article-title":"Pathophysiology of the basal ganglia in Parkinson\u2019s disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2005.10.022_bib21","first-page":"S167","article-title":"Preventing levodopa-induced dyskinesias","volume":"47","author":"Olanow","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.10.022_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM200107123450214","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson\u2019s disease","volume":"345","author":"Olanow","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2005.10.022_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson\u2019s disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.10.022_bib24","first-page":"698","article-title":"Risk factor for motor response complications in l-dopa-treated Parkinsonian patients","volume":"60","author":"Peppe","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.expneurol.2005.10.022_bib25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/mthe.2001.0466","article-title":"Functional effect of adeno-associated virus mediated gene transfer of aromatic l-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats","volume":"4","author":"Sanchez-Pernaute","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2005.10.022_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0091-3057(89)90372-9","article-title":"Levodopa-induced dyskinesias in parkinsonian monkeys: relationship to extent of nigrostriatal damage","volume":"34","author":"Schneider","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.expneurol.2005.10.022_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0006-8993(03)03382-1","article-title":"Development of levodopa-induced dyskinesias in parkinsonian monkeys may depend upon rate of symptom onset and\/or duration of symptoms","volume":"990","author":"Schneider","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.10.022_bib28","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/mds.10588","article-title":"Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats","volume":"18","author":"Steece-Collier","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2005.10.022_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.2953072","article-title":"D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects","volume":"236","author":"Walters","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2005.10.022_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/mds.870090208","article-title":"Severe evening dyskinesias in advanced Parkinson\u2019s disease: clinical description, relation to plasma levodopa, and treatment","volume":"9","author":"Zimmerman","year":"1994","journal-title":"Mov. Disord."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488605003584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488605003584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T15:53:40Z","timestamp":1547913220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488605003584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0014488605003584"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2005.10.022","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}